CircRNA合成の市場規模、シェア、動向分析レポート：製品・サービス別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

CircRNA合成市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のCircRNA合成市場規模は2030年までに4億4,250万米ドルに達し、予測期間中の2025～2030年のCAGRは15.88％で成長すると予測されています。

サーキュラーRNA合成産業は、サーキュラーRNAの治療可能性を強調する継続的な研究開発努力に牽引され、大きな成長を遂げています。サーシオの科学者が最近Nature Reviews Genetics誌に発表した包括的な総説は、強化された安定性や優れた免疫学的プロファイルなど、CircRNAのユニークな特性を強調しており、感染症、CAR-T療法、遺伝子治療など、さまざまな治療用途の有望な候補となっています。本書は、CircRNA治療における現在の進歩を強調するだけでなく、このセグメントにおける機会と課題を明らかにすることで、さらなる投資と探求を促しています。

企業間の戦略的提携も市場を前進させています。例えば、2024年1月、Circioは4basebioと提携し、遺伝子医療とワクチン用の合成circVec DNAベクターの開発と検査を行っています。この提携は、CircioのcircVec環状RNA発現システムと、4basebio独自の合成DNAフォーマットと独自のナノ粒子送達プラットフォームであるHermesを組み合わせ、強力な治療コンビネーションを生み出すことを目的としています。このような提携は、将来の合成DNA遺伝子治療のための、耐久性があり、繰り返し使用可能な、非ウイルス性プラットフォームの開発を進める上で重要です。

CircRNA生産技術の革新は、市場拡大をさらに後押ししています。例えば、2024年8月、Abogen Biosciencesは、Cis-Systemと呼ばれる、環状RNAの生産を可能にする非常に効率的なRNA環状化シスプライシングシステムの開発を発表しました。この独自のシステムは、世界の知的財産権を有するだけでなく、既存の方法よりも改善され、CircRNA生産の効率とスケーラビリティを向上させる可能性があります。このような技術的進歩は、CircRNAを治療やワクチンに幅広く応用する上で極めて重要であり、市場成長の原動力となっています。

CircRNA合成市場レポートハイライト

• 試薬・キットセグメントは、2024年に47.29%の最大収益シェアを獲得。研究と治療開発におけるCircRNA技術の採用が増加しています。研究者は、安定した機能的なCircRNAを生産するために、効率的な環化プロセス、ベクター構築、精製のための高品質の試薬とキットを必要としています。
• 2024年には、CircRNA用に調整された脂質ナノ粒子（LNPs）などの送達システムの進歩により、効率的で正確な治療応用が可能になり、治療開発が最大の収益シェアを占めています。curRNA治療に焦点を当てた前臨床と臨床研究の数が増加していることは、この市場が現代医療を変革する可能性があることを裏付けています。
• 最終用途別では、製薬・バイオテクノロジー企業セグメントが2024年に59.55%の最大収益シェアを獲得しました。同市場は、革新的な治療法やワクチンへの可能性を活用することで、CircRNA合成産業の成長を牽引しています。
• 北米地域は2024年に45.12%の市場シェアを占めました。この市場を牽引しているのは、RNAベースの研究に対する旺盛な投資、バイオテクノロジー企業や製薬企業の存在感、RNA治療やワクチンへの関心の高まりです。NIH助成金などの政府資金や学術共同研究は、このセグメントの進歩をさらに後押ししています。さらに、この地域には臨床検査や最先端技術のためのインフラが確立されており、CircRNAプラットフォームの採用を加速させています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 CircRNA合成市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 産業分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 CircRNA合成市場：製品・サービス別、推定・動向分析

• 製品・サービスセグメントダッシュボード
• 世界のCircRNA合成市場の製品・サービスの変動分析
• 世界のCircRNA合成市場規模と動向分析、製品・サービス別、2018～2030年
• 試薬とキット
• 機器
• サービス

第5章 CircRNA合成市場：用途別、推定・動向分析

• 用途セグメントダッシュボード
• 世界のCircRNA合成市場の用途の変動分析
• 世界のCircRNA合成市場規模と動向分析、用途別、2018～2030年
• 治療開発
• 創薬
• その他

第6章 CircRNA合成市場：最終用途別、推定・動向分析

• 最終用途セグメントダッシュボード
• 世界のCircRNA合成市場の最終用途の変動分析
• 世界のCircRNA合成市場の規模と動向分析、最終用途別、2018～2030年
• 製薬・バイオテクノロジー企業
• 学術研究機関
• その他

第7章 CircRNA合成市場：地域別、推定・動向分析

• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 市場規模と予測と動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 参入企業
• 企業市況分析、2024年
• 参入企業概要
  • LGC Biosearch Technologies
  • Creative Biogene
  • SBS Genetech
  • Applied Biological Materials Inc
  • GenScript
  • Amerigo Scientific
  • BOC Sciences
  • GeneCopoeia, Inc.
  • Guangzhou Geneseed BIoTech. Co., Ltd.
  • Creative Biolabs

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Global circRNA synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 4 Global circRNA synthesis market, by application, 2018 - 2030 (USD Million)
• Table 5 Global circRNA synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 6 Global circRNA synthesis market, by region, 2018 - 2030 (USD Million)
• Table 7 North America circRNA synthesis market, by country, 2018 - 2030 (USD Million)
• Table 8 North America circRNA synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 9 North America circRNA synthesis market, by application, 2018 - 2030 (USD Million)
• Table 10 North America circRNA synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 11 U.S. circRNA synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 12 U.S. circRNA synthesis market, by application, 2018 - 2030 (USD Million)
• Table 13 U.S. circRNA synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 14 Canada circRNA synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 15 Canada circRNA synthesis market, by application, 2018 - 2030 (USD Million)
• Table 16 Canada circRNA synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 17 Mexico circRNA synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 18 Mexico circRNA synthesis market, by application, 2018 - 2030 (USD Million)
• Table 19 Mexico circRNA synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 20 Europe circRNA synthesis market, by country, 2018 - 2030 (USD Million)
• Table 21 Europe circRNA synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 22 Europe circRNA synthesis market, by application, 2018 - 2030 (USD Million)
• Table 23 Europe circRNA synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 24 UK circRNA synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 25 UK circRNA synthesis market, by application, 2018 - 2030 (USD Million)
• Table 26 UK circRNA synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 27 Germany circRNA synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 28 Germany circRNA synthesis market, by application, 2018 - 2030 (USD Million)
• Table 29 Germany circRNA synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 30 France circRNA synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 31 France circRNA synthesis market, by application, 2018 - 2030 (USD Million)
• Table 32 France circRNA Synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 33 Italy circRNA Synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 34 Italy circRNA Synthesis market, by application, 2018 - 2030 (USD Million)
• Table 35 Italy circRNA Synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 36 Spain circRNA Synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 37 Spain circRNA Synthesis market, by application, 2018 - 2030 (USD Million)
• Table 38 Spain circRNA Synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 39 Denmark circRNA Synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 40 Denmark circRNA Synthesis market, by application, 2018 - 2030 (USD Million)
• Table 41 Denmark circRNA Synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 42 Sweden circRNA Synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 43 Sweden circRNA Synthesis market, by application, 2018 - 2030 (USD Million)
• Table 44 Sweden circRNA Synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 45 Norway circRNA Synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 46 Norway circRNA Synthesis market, by application, 2018 - 2030 (USD Million)
• Table 47 Norway circRNA Synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific circRNA Synthesis market, by country, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific circRNA Synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific circRNA Synthesis market, by application, 2018 - 2030 (USD Million)
• Table 51 Asia Pacific circRNA Synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 52 Japan circRNA Synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 53 Japan circRNA Synthesis market, by application, 2018 - 2030 (USD Million)
• Table 54 Japan circRNA Synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 55 China circRNA Synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 56 China circRNA Synthesis market, by application, 2018 - 2030 (USD Million)
• Table 57 China circRNA Synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 58 India circRNA Synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 59 India circRNA Synthesis market, by application, 2018 - 2030 (USD Million)
• Table 60 India circRNA Synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 61 Australia circRNA Synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 62 Australia circRNA Synthesis market, by application, 2018 - 2030 (USD Million)
• Table 63 Australia circRNA Synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 64 Thailand circRNA Synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 65 Thailand circRNA Synthesis market, by application, 2018 - 2030 (USD Million)
• Table 66 Thailand circRNA Synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 67 South Korea circRNA Synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 68 South Korea circRNA Synthesis market, by application, 2018 - 2030 (USD Million)
• Table 69 South Korea circRNA Synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 70 Latin America circRNA Synthesis market, by country, 2018 - 2030 (USD Million)
• Table 71 Latin America circRNA Synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 72 Latin America circRNA Synthesis market, by application, 2018 - 2030 (USD Million)
• Table 73 Latin America circRNA Synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 74 Brazil circRNA Synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 75 Brazil circRNA Synthesis market, by application, 2018 - 2030 (USD Million)
• Table 76 Brazil circRNA Synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 77 Argentina circRNA Synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 78 Argentina circRNA Synthesis market, by application, 2018 - 2030 (USD Million)
• Table 79 Argentina circRNA Synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa circRNA Synthesis market, by country, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa circRNA Synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa circRNA Synthesis market, by application, 2018 - 2030 (USD Million)
• Table 83 Middle East & Africa circRNA Synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 84 South Africa circRNA Synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 85 South Africa circRNA Synthesis market, by application, 2018 - 2030 (USD Million)
• Table 86 South Africa circRNA Synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia circRNA Synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia circRNA Synthesis market, by application, 2018 - 2030 (USD Million)
• Table 89 Saudi Arabia circRNA Synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 90 UAE circRNA Synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 91 UAE circRNA Synthesis market, by application, 2018 - 2030 (USD Million)
• Table 92 UAE circRNA Synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 93 Kuwait circRNA Synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 94 Kuwait circRNA Synthesis market, by application, 2018 - 2030 (USD Million)
• Table 95 Kuwait circRNA Synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 96 Participant's overview
• Table 97 Financial performance
• Table 98 Key companies undergoing expansions
• Table 99 Key companies undergoing acquisitions
• Table 100 Key companies undergoing collaborations
• Table 101 Key companies launching new product & services
• Table 102 Key companies undertaking other strategies

List of Figures

• Fig. 1 CircRNA synthesis market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Market formulation & validation
• Fig. 7 Market outlook
• Fig. 8 Segment snapshot
• Fig. 9 Competitive landscape snapshot
• Fig. 10 Parent market outlook
• Fig. 11 CircRNA Synthesis market driver analysis
• Fig. 12 CircRNA Synthesis market restraint analysis
• Fig. 13 CircRNA Synthesis market: Porter's analysis
• Fig. 14 CircRNA Synthesis market: PESTEL analysis
• Fig. 15 CircRNA Synthesis market: Product & service outlook and key takeaways
• Fig. 16 CircRNA Synthesis market: Product & service market share analysis, 2024 - 2030
• Fig. 17 Global circRNA Synthesis market for reagents & kits, 2018 - 2030 (USD Million)
• Fig. 18 Global circRNA Synthesis market for instruments, 2018 - 2030 (USD Million)
• Fig. 19 Global circRNA Synthesis market for services, 2018 - 2030 (USD Million)
• Fig. 20 CircRNA Synthesis market: Application outlook and key takeaways
• Fig. 21 CircRNA Synthesis market: Application market share analysis, 2024 - 2030
• Fig. 22 Global circRNA Synthesis market for therapeutics development, 2018 - 2030 (USD Million)
• Fig. 23 Global circRNA Synthesis market for drug discovery, 2018 - 2030 (USD Million)
• Fig. 24 Global circRNA Synthesis market for other applications, 2018 - 2030 (USD Million)
• Fig. 25 CircRNA Synthesis market: End use outlook and key takeaways
• Fig. 26 CircRNA Synthesis market: End use market share analysis, 2024 - 2030
• Fig. 27 Global circRNA Synthesis market for pharmaceutical and biotechnology companies, 2018 - 2030 (USD Million)
• Fig. 28 Global circRNA Synthesis market for academic & research institutes, 2018 - 2030 (USD Million)
• Fig. 29 Global circRNA Synthesis market for others, 2018 - 2030 (USD Million)
• Fig. 30 Regional marketplace: Key takeaways
• Fig. 31 North America circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 U.S. circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Canada circRNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 34 Mexico circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Europe circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36 UK circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 Germany circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 France circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 Italy circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 40 Spain circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 41 Denmark circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 42 Sweden circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43 Norway circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 44 Asia-Pacific circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 45 Japan circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 46 China circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 47 India circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48 Australia circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 49 Thailand circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 50 South Korea circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 51 Latin America circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 52 Brazil circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 53 Argentina circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 54 MEA circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 55 South Africa circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 56 Saudi Arabia circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 57 UAE circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 58 Kuwait circRNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 59 Key company categorization
• Fig. 60 Company market positioning
• Fig. 61 Market participant categorization
• Fig. 62 Strategy framework

CircRNA Synthesis Market Growth & Trends:

The global circRNA synthesis market size is anticipated to reach USD 442.5 million by 2030 and grow at a CAGR of 15.88% from 2025 to 2030 during the forecast period, according to a new report by Grand View Research, Inc. The circRNA synthesis industry is experiencing significant growth, driven by ongoing research and development efforts that highlight the therapeutic potential of circular RNAs. A recent comprehensive review published in Nature Reviews Genetics by Circio scientists underscores the unique properties of circRNAs, such as enhanced stability and superior immunological profiles, which make them promising candidates for various therapeutic applications, including infectious diseases, CAR-T therapy, and gene therapy. This publication not only emphasizes the current advancements in circRNA therapeutics but also identifies opportunities and challenges in the field, thereby encouraging further investment and exploration.

Strategic collaborations between companies are also propelling the market forward. For instance, in January 2024, Circio has partnered with 4basebio to develop and test synthetic circVec DNA vectors for genetic medicine and vaccines. This partnership aims to combine Circio's circVec circular RNA expression system with 4basebio's proprietary synthetic DNA formats and unique nanoparticle delivery platform, Hermes, to create a powerful therapeutic combination. Such alliances are instrumental in advancing the development of durable, repeat-dosable, non-viral platforms for future synthetic DNA gene therapies.

Innovations in circRNA production technologies are further driving market expansion. For instance, in August 2024, Abogen Biosciences, has announced the development of a highly efficient RNA circularization cis-splicing system, referred to as the Cis-System, which enables the production of circular RNA. This proprietary system not only holds global intellectual property rights but also offers improvements over existing methods, potentially enhancing the efficiency and scalability of circRNA production. Such technological advancements are crucial for the broader application of circRNA in therapeutics and vaccines, thereby fueling market growth.

CircRNA Synthesis Market Report Highlights:

• The reagents and kits segment captured the largest revenue share of 47.29% in 2024. The increasing adoption of circRNA technologies in research and therapeutic development. Researchers require high-quality reagents and kits for efficient circularization processes, vector construction, and purification to produce stable and functional circRNAs.
• In 2024, therapeutics development dominated the market with the largest revenue share, driven by the advancements in delivery systems, such as lipid nanoparticles (LNPs) tailored for circRNA, are enabling efficient and precise therapeutic applications. The rising number of preclinical and clinical studies focused on circRNA therapeutics underscores the market's potential to transform modern medicine.
• By end use, the pharmaceutical and biotechnology companies segment captured the largest revenue share of 59.55% in 2024. The market is driving growth in the circRNA synthesis industry by leveraging its potential for innovative therapies and vaccines.
• The North American region dominated the market share of 45.12% in 2024. The market is driven by robust investments in RNA-based research, a strong presence of biotech and pharmaceutical companies, and growing interest in RNA therapeutics and vaccines. Government funding, such as NIH grants, and academic collaborations further support advancements in the field. Additionally, the region's established infrastructure for clinical trials and cutting-edge technologies accelerates the adoption of circRNA platforms.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product & Service
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. CircRNA Synthesis Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Advancements in RNA-Based Therapeutics
    • 3.2.1.2. Increased Research Investment
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Technical Challenges in Production and Delivery
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. CircRNA Synthesis Market: Product & Services Estimates & Trend Analysis

• 4.1. Product & Service Segment Dashboard
• 4.2. Global CircRNA Synthesis Market Product & Service Movement Analysis
• 4.3. Global CircRNA Synthesis Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
• 4.4. Reagents & Kits
  • 4.4.1. Reagents & Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Instruments
  • 4.5.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Services
  • 4.6.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. CircRNA Synthesis Market: Application Estimates & Trend Analysis

• 5.1. Application Segment Dashboard
• 5.2. Global CircRNA Synthesis Market Application Movement Analysis
• 5.3. Global CircRNA Synthesis Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Therapeutics Development
  • 5.4.1. Therapeutics Development Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Drug Discovery
  • 5.5.1. Drug Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Other Applications
  • 5.6.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. CircRNA Synthesis Market: End Use Estimates & Trend Analysis

• 6.1. End Use Segment Dashboard
• 6.2. Global CircRNA Synthesis Market End Use Movement Analysis
• 6.3. Global CircRNA Synthesis Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Pharmaceutical & Biotechnology Companies
  • 6.4.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Academic & Research Institutes
  • 6.5.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. CircRNA Synthesis Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 7.4. North America
  • 7.4.1. North America CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. U.S. CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Canada CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. Mexico CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. UK CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Germany CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. France CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Italy CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Spain CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Denmark CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Sweden CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Norway CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Japan CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. China CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. India CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Australia CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Thailand
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Thailand CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. South Korea
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. South Korea CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Brazil CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Argentina CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. South Africa CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Saudi Arabia CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. UAE CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Kuwait CircRNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Categorization
• 8.2. Company Market Position Analysis, 2024
• 8.3. Participant's Overview
  • 8.3.1. LGC Biosearch Technologies
    • 8.3.1.1. Participant's Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Product/Service Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. Creative Biogene
    • 8.3.2.1. Participant's Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Product/Service Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. SBS Genetech
    • 8.3.3.1. Participant's Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Product/Service Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Applied Biological Materials Inc
    • 8.3.4.1. Participant's Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Product/Service Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. GenScript
    • 8.3.5.1. Participant's Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Product/Service Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Amerigo Scientific
    • 8.3.6.1. Participant's Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Product/Service Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. BOC Sciences
    • 8.3.7.1. Participant's Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Product/Service Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. GeneCopoeia, Inc.
    • 8.3.8.1. Participant's Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Product/Service Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Guangzhou Geneseed Biotech. Co., Ltd.
    • 8.3.9.1. Participant's Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Product/Service Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. Creative Biolabs
    • 8.3.10.1. Participant's Overview
    • 8.3.10.2. Financial Performance
    • 8.3.10.3. Product/Service Benchmarking
    • 8.3.10.4. Strategic Initiatives